If the past few weeks are any indication, pharmacy isn’t going to be the same for very long.
Andaxanet alfa has shown effectiveness for patients needing hemostasis.
Easy-to-swallow news and studies for the busy pharmacist.
Zinbryta was taken off the market, leaving many patients with poor options.
Amazon quietly rolled out a line of OTC products—and that should scare you.
An independent pharmacy opted to settle a wrongful death lawsuit involving an opioid prescription.
In an effort to combat opioids, the FDA is pushing blister packs—something pharmacy groups have been advocating for.
Pharmacy groups are praising new Medicare Part D opioid limits.
Three medical groups have issued guidelines for the use of anticoagulants during cardiac surgery.
The DOAC edoxaban can replace dalteparin for treating cancer patients with venous thromboembolism.